Letter to the Editor: Business Roundtable vs. the social contract

Letter to the Editor: Karen Bernstein argues against the Business Roundtable’s resolution and its relevance for the social contract

In a Sept. 13 Editor’s Comment in BioCentury, our Washington Editor Steve Usdin writes about the importance of the biopharmaceutical industry renewing its commitments to the social contract under which corporations do business and reap profits in the expectation that society is better off when they do.

Usdin’s commentary was triggered by the recent “Statement of Purpose of a Corporation” by the Business Roundtable, which rewrote the corporate mission to add

Read the full 703 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers